Clinical study of Chinese herbs for reinforcing 'shen' and supplementing 'qi' in the prevention and cure of bronchial asthma

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2009
INTERVENTION: Group B:Budisonide+Bushen Fangchuan Pian(5 tablets,tid,orally taken for 12 weeks);Group A:Budisonide+chinese drugs for reinforcing shen and supplementing qi(125ml,bid,orally taken for 12 weeks);Group C:Budisonide+Chinese drugs for reinforcing shen and supplementing qi placebo+Bushen Fangchuan Pian placebo; CONDITION: Bronchial asthma PRIMARY OUTCOME: Asthma control test; SECONDARY OUTCOME: Asthma symptoms, lung function, Asthma Quality of Life, Questionnaire, traditional Chinese syndrome, blood cell count; INCLUSION CRITERIA: 1.Aged 18 to 70 years old, male or female; 2.Able and willing to provide signed informed consent; 3.Patients with partial controlled and uncontrolled asthma, and using inhaled corticosteroid treatment continuously at least three months; 4.Qi deficiency syndrome,shen qi deficiency syndrome and deficiency of Shenyang syndrome according to Traditional Chinese medical Differentiation; 5.Without Respiratory tract infection and Acute asthma attack for the past four weeks.
Epistemonikos ID: e779175c285e245c6588c4e8d3ab4aa4647b1b90
First added on: Aug 22, 2024